Oxytetracycline

Table of contents

  • Brand Names
  • Drug Combinations
  • Chemistry
  • Pharmacologic Category
  • Mechanism of Action
  • Therapeutic Use
  • Pregnancy and Lactation Implications
  • Contraindications
  • Warnings and Precautions
  • Adverse Reactions
  • Toxicological Effects
  • Genes that may be involved
  • Induces
  • Drug Interactions
  • Nutrition/Nutraceutical Interactions
  • Dosage
  • Pharmacokinetics and Pharmacodynamics
  • Special Considerations

Brand Names

Europe

Austria: Aerocyclin, Ani-Oxypre-Pulver für Tiere, Cuxacyclin, Cyclosol, Duphacyclin XL, Hostacyclin LA, Medicyclin, OTC, Oxycyclin, Oxyject, Oxytetra, Oxytetracyclin, Terramycin, Tetrasol, Ursocyclin, Vanacyclin; Denmark: Oxytetral; France: Innolyre, Oxytetracycline, Posicycline, Terramycine, Tetranase; Germany: Baxyl LA, Cuxacyclin, Medox, OTC-Blauspray, Oxipra, Oxytetracyclin, Terramycin, Tridox, Ursocyclin; Greece: Oxacycle, Oxycyclin, Oxytetracycline, Terine, Terramycin; Hungary: Tetran; Ireland: Oxytetracyclin; Portugal: Terricil; Spain: Terramicina; Sweden: Oxytetral; UK: Oxytetracycline.

North America

USA: Terramycin.

Latin America

Argentina: Terramicina; Brazil: Terramicina; Mexico: Metrecina, Oxitraklín, Terrados, Terramicina.

Asia

Japan: Oxytetra Cone, Terramycin.

Drug combinations

Oxytetracycline and Dexamethasone

Oxytetracycline and Hydrocortisone

Oxytetracycline and Polymyxin B

Oxytetracycline and Prednisolone

Oxytetracycline, Hydrocortisone, and Polymyxin B

Chemistry

Oxytetracycline: C~22~H~24~N~2~O~9~ 2H~2~O. Mw: 496.47. (1) 2-Naphthacenecarboxamide,4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-,[4S-(4α,4aα,5α,5aα,6β,12aα)]-,dihydrate; (2) 4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-2-naphthacene-carboxamide dihydrate. CAS-6153-64-6. CAS-79-57-2 (anhydrous).

Pharmacologic Category

Antibacterials, Tetracyclines. EENT Preparations; Antibacterials. Skin and Mucous Membrane Agents; Antibacterials. (ATC-Code: D06AA03; G01AA07; J01AA06; S01AA04).

Mechanism of action

Inhibits bacterial protein synthesis by binding with 30 S and possibly 50 S ribosomal subunit(s) of susceptible bacteria; cell wall synthesis not affected.

Therapeutic use

Treatment of susceptible bacterial infections; both Gram-positive and Gram-negative, as well as Rickettsia and Mycoplasma organisms.

Pregnancy and lactiation implications

Tetracyclines not recommended for use during pregnancy. Lactation not recommended.

Unlabeled use

Contraindications

Hypersensitivity to tetracycline or any component of the formulation.

Warnings and precautions

Avoid in children ≤8 years of age, pregnant and nursing women. Photosensitivity can occur with oxytetracycline. Photosensitivity manifested by exaggerated sunburn reaction observed in some individuals taking tetracyclines. Discontinue treatment at first evidence of skin erythema. Antianabolic action of tetracyclines may cause increase in BUN (may lead to azotemia, hyperphosphatemia, and acidosis). Avoid use in severe liver disease. Injection for I.M. use only.

Information

Legal

Legal Notice
Privacy Policy
Cookie Policy

Contact

Phone: +34-981-780505
Email: genomicmedicine@wagem.org
Location: Sta Marta de, C. P. Babío, S/N, 15165 Bergondo, A Coruña

Copyright © 2023 WAGEM

Add to cart